BeOne Medicines Ltd. Non-operating Income/Expense 2014-2026 | ONC
Beta
What is BeOne Medicines Ltd.'s current non-operating income/expense?
BeOne Medicines Ltd. (ONC) annual non-operating income/expense for 2025 was $-42.6M, a 236.71% decline from 2024. BeOne Medicines Ltd. non-operating income/expense for the quarter ending March 31, 2026 was $14.5M.
What was BeOne Medicines Ltd.'s non-operating income/expense in 2024?
BeOne Medicines Ltd. annual non-operating income/expense for 2024 was $-12.6M, a 104.10% decline from 2023.
What was BeOne Medicines Ltd.'s non-operating income/expense in 2023?
BeOne Medicines Ltd. annual non-operating income/expense for 2023 was $307.9M, a 237.54% increase from 2022.
Non-operating Income/Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGRN/A
FY2020
$37.5M
→
FY2025
$-42.6M
141516171819202122232425
5 years selected
Non-operating Income/Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $-42.6M | -236.7% | 10-K |
| FY2024 | $-12.6M | -104.1% | 10-K |
| FY2023 | $307.9M | +237.5% | 10-K |
| FY2022 | $-223.9M | -1507.5% | 10-K |
| FY2021 | $15.9M | -57.6% | 10-K |
| FY2020 | $37.5M | +422.6% | 10-K |
| FY2019 | $7.2M | +260.0% | 10-K |
| FY2018 | $2.0M | -82.7% | 10-K |
| FY2017 | $11.5M | +1283.2% | 10-K |
| FY2016 | $-972,000 | -179.4% | 10-K |
| FY2015 | $1.2M | +104.0% | 10-K |
| FY2014 | $600,000 | - | 10-K |
Company: BeOne Medicines Ltd.Ticker: ONCSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →